Iguana Healthcare Management’s Gilead Sciences GILD Stock Holding History

Iguana Healthcare Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-25,000	Closed	-$1.7M	–	68
2017 Q1	$1.7M	Hold	25,000	–	–	0.84%	41
2016 Q4	$1.79M	Sell	25,000 -95,000	-79%	-$7.06M	1.07%	32
2016 Q3	$9.49M	Sell	120,000 -15,000	-11%	-$1.22M	1.69%	20
2016 Q2	$11.3M	Buy	135,000 +50,000	+59%	+$4.44M	4.58%	3
2016 Q1	$7.81M	Sell	85,000 -5,000	-6%	-$451K	2.86%	11
2015 Q4	$9.11M	Sell	90,000 -10,000	-10%	-$1.04M	3%	9
2015 Q3	$9.82M	Hold	100,000	–	–	3.86%	6
2015 Q2	$11.7M	Hold	100,000	–	–	3.69%	7
2015 Q1	$9.81M	Sell	100,000 -25,000	-20%	-$2.54M	4.13%	5
2014 Q4	$11.8M	Buy	125,000 +7,500	+6%	+$776K	5.69%	3
2014 Q3	$12.5M	Buy	117,500 +42,500	+57%	+$4.16M	6.68%	2
2014 Q2	$6.22M	Buy	75,000 +25,000	+50%	+$1.95M	2.9%	8
2014 Q1	$3.54M	Sell	50,000 -35,000	-41%	-$2.74M	1.64%	21
2013 Q4	$6.38M	Buy	+85,000	New	+$5.92M	3.64%	6

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Iguana Healthcare Management's GILD Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 25,000 shares — an estimated $1.7M sold.

Iguana Healthcare Management first reported a position in GILD in Q4 2013 and held it in 14 quarters. The position peaked at $12.5M in Q3 2014. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Iguana Healthcare Management reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
Iguana Healthcare Management sold 25,000 Gilead Sciences shares in Q2 2017, an estimated $1.7M.
Iguana Healthcare Management first reported a position in Gilead Sciences in Q4 2013 and held it in 14 quarters.
Iguana Healthcare Management's Gilead Sciences position peaked at $12.5M in Q3 2014.
1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.